---
title: "Bio-S released its performance for the first three quarters, with a net profit attributable to the parent company of 6.1242 million yuan, a decrease of 95.68%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262638651.md"
description: "According to the Zhitong Finance APP, Bio-S released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 510 million yuan, a year-on-year decrease of 29.33%. The net profit attributable to shareholders of the listed company was 6.1242 million yuan, a year-on-year decrease of 95.68%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 13.9173 million yuan. The basic earnings per share were 0.06 yuan"
datetime: "2025-10-24T13:01:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262638651.md)
  - [en](https://longbridge.com/en/news/262638651.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262638651.md)
---

# Bio-S released its performance for the first three quarters, with a net profit attributable to the parent company of 6.1242 million yuan, a decrease of 95.68%

According to the Zhitong Finance APP, Bio-S (301096.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 510 million yuan, a year-on-year decrease of 29.33%. The net profit attributable to shareholders of the listed company was 6.1242 million yuan, a year-on-year decrease of 95.68%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 13.9173 million yuan. The basic earnings per share were 0.06 yuan

### Related Stocks

- [301096.CN](https://longbridge.com/en/quote/301096.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [NorthPalm Capital Launches as AI-Augmented Investment Company | SCYRF Stock News](https://longbridge.com/en/news/286914222.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [US working with small biotech firm on experimental Ebola treatment, Bloomberg News reports](https://longbridge.com/en/news/287108072.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)